Jun 30, 2026
AbbVie (ABBV) stock: bull, base, and bear case from 6 months to 5 years
AbbVie (ABBV) forecast with bull, base, bear scenarios across 6 months, 1 year, 3 years, and 5 years. Skyrizi-Rinvoq growth vs. IRA drug pricing and patent cliff; Buy rating, Fair valuation.
